Robyn Laura Kosinsky was born in Emmerich am Rhein, Germany, in 1988. She obtained her Bachelor’s degrees in Life Sciences and Applied Biology at the HAN University of Applied Sciences, The Netherlands, and Bonn-Rhein-Sieg University of Applied Sciences, Germany. To understand disease-relevant molecular mechanisms, she completed her Master of Science in Molecular Medicine at the Georg-August University Göttingen, Germany. During her PhD, Robyn evaluated the function of a deubiquitinating enzyme in intestinal organ maintenance and the development of colorectal cancer (CRC) in the group of Dr. Steven A. Johnsen at the University Medical Center Göttingen. Afterwards, she acquired funding for women in leadership positions as well as further third-party funding to focus on epigenetic mechanisms related to intestinal inflammation as well as inflammation-associated and sporadic CRC. Based on her dedication to teaching and her academic achievements, she was awarded the Venia Legendi (habilitation) in Molecular Medicine in 2020. To extend her knowledge on epigenetic (de)regulation in immune regulatory cells in chronic intestinal inflammation, she acquired a Mildred-Scheel Postdoctoral Fellowship (Deutsche Krebshilfe). Under the supervision of Dr. William A. Faubion she focused on T cell biology in Crohn’s disease within the Division of Gastroenterology and Hepatology at the Mayo Clinic in Rochester, Minnesota, USA. At the end of her research stay, she has obtained the rank of Adjunct Assistant Professor of Medicine at Mayo Clinic. In May 2022, Robyn assumed the position as a group leader at the Robert Bosch Center for Tumor Diseases where she and her team will elucidate epigenetic mechanisms in inflammation-driven tumorigenesis.
☛ Check out the Kosinsky Lab on Instagram
Relevant Own Publications
See more on ORCID